DELSTRIGO

Identification of Delstrigo

No description

Google image searchProduct monograph

Active ingredients

doravirine, 100 MG

lamivudine, 300 MG

tenofovir disoproxil fumarate, 300 MG

DIN: 02482592

Dosage form(s): TABLET

Route(s) of administration: ORAL

Schedule: Prescription

Company: MERCK CANADA INC

Date: 10-DEC-2018

ATC:

• J05 — ANTIVIRALS FOR SYSTEMIC USE (ATC, ATC/DDD, )
• J05A — DIRECT ACTING ANTIVIRALS (ATC, ATC/DDD)
• J05AR — Antivirals for treatment of HIV infections, combinations (ATC, ATC/DDD)
• J05AR24 — LAMIVUDINE, TENOFOVIR DISOPROXIL AND DORAVIRINE (ATC/DDD)

External Links for Delstrigo

Search on Google

• Delstrigo side effects
• Delstrigo dosage
• doravirine side effects
• doravirine dosage
• lamivudine side effects
• lamivudine dosage
• tenofovir disoproxil fumarate side effects
• tenofovir disoproxil fumarate dosage

Merck Canada Inc

Go to Merck website to see drug product details. Sometimes you can find delstrigo photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.